Panion Animal Health is specialised in the development of gene therapy for the treatment of epilepsy in dogs and other pets. The products consist of a number of veterinary products and other forms of treatment. Today business is operated in Europe and North America. The company was established in 2005 as a subsidiary of CombiGene. The company is based in Hässleholm.

Quotes for Panion Animal Health AB

Right Now

+/-
0
%
0,00%
Latest
0.628
High
0.628
Low
0.628
Volume
1 500
Turnover (SEK)
942
Value (MSEK)
20,5

Board

CEO

  • Anja Holm

Chairman Of The Board

  • Arne Ferstad

Board

  • Jan Nilsson
  • Lars Thunberg

Videos

Upcoming reports

  • 2019-09-30

  • 2019-11-21 Delårsrapport 2019-Q3